Pyogenic granuloma (PG) generally appears in the skin or oral cavity, but rarely occurs in the small intestine, where it can cause bleeding. To date, only 35 cases of small intestinal PG have been reported in the English literature. We retrospectively collected information from the clinical records of seven cases of small intestinal PG that were managed in our hospital and summarized the characteristics. Further information on the clinical characteristics was obtained from the literature. Capsule endoscopy, useful for identifying the source of hemorrhage in obscure gastrointestinal bleeding, can detect PGs. Treatment can often be accomplished with endoscopic mucosal resection.
Introduction
Pyogenic granuloma (PG) is a capillary hemangioma first reported in 1897 by Poncet et al. (1) who called it Botryomycosis humaine; however, in 1904, Hartzell (2) named it as pyogenic granuloma. PGs generally occur on the skin or in the oral cavity. In contrast, they are rarely reported in the digestive tract (3) .
Small intestinal bleeding is uncommon, accounting for only approximately 4% of all cases of gastrointestinal hemorrhage. Angiodysplasias and tumors are the most common causes of small intestinal bleeding (4) . There are few reports of bleeding caused by PG in the small intestine (35 case reports). We herein describe a series of cases of small intestinal PG, and review the clinical and endoscopic features of our patients and those reported in the literature. women. Anemia, hematochezia, and melena were the main presenting signs. Laboratory examination revealed iron deficiency anemia in many cases, with an average hemoglobin level of 9.14 g/dL. Comorbidities included liver disease in three patients and renal disease in three patients, two of whom were on dialysis. Three patients were taking anticoagulant or antiplatelet drugs. The endoscopic characteristics of the eight lesions are summarized in Table 2 . Three-quarters (6/8) of the PGs were located in the ileum. Patient 3 had two metachronous lesions at different sites, so the second was not thought to be a recurrence of the first polyp, which had been treated with endoscopic mucosal resection (EMR). The average tumor size was 5.9 mm, all PGs were <10 mm in size and semi-pedunculated. Although single capsule endoscopy (CE) localized the lesions in some cases, in other cases, repeat CE and/or single-balloon enteroscopy (SBE) was needed before the PG was found. CE found the lesions in half of the cases. Six PGs were treated with EMR, and two were surgically resected. In Patient 2, CE detected bleeding from a 5mm semi-pedunculated polyp in the ileum (Fig. 1a ), which was also seen on SBE ( Fig. 1b ). Endoscopic ultrasonography (EUS) showed that the muscle layer and tumor could not be clearly distinguished (Fig. 1c) . Thus, the lesion was tattooed with black ink and was subsequently removed surgically. Surgery was performed in the other case because, when EMR was attempted, the tumor did not lift after submucosal injection. The pathology findings from Patient 2 are shown in Fig. 2 . Hematoxylin and Eosin staining showed increased, lobulated, and enlarged capillaries and desquamated epithelium, indicating epithelial erosion ( Fig. 2a ). Immunostaining with CD34, a marker of vascular endothelial cells, showed capillary proliferation ( Fig. 2b ).
Discussion
PG is a painless, capillary-proliferative lesion that can cause gastrointestinal hemorrhage if located in the digestive tract. It is commonly dark black or bright red, often in the form of stalked or semi-pedunculated polyps. The surface frequently becomes ulcerated. The etiology is thought to be infection or irritation-induced granulation, with 38-70.5% of patients reported to have a history of trauma or infection. In the oral cavity, many patients have a history of chronic irritation from ill-fitting dentures, bites, or sharp teeth. Chronic irritation, such as mucosal damage from fish bones or exposure to gastric acid is reportedly a cause of PG in the gastrointestinal tract. On the other hand, there are also reports of some cases sin which PG developed without trauma or a specifically identified trigger (5) . Histopathologically, PG is a hemangioma characterized by lobule-like growth of capillaries with enlarged vascular endothelial cells and inflamma- Table 3 . Melena was the most frequent presenting sign, followed by anemia. Three patients presented with hematochezia. Data on hemoglobin and comorbidities were available for nearly half of the cases. The average hemoglobin level was 7.96 g/dL. A range of comorbidities were observed, including renal disease (n=3) liver disease (n=3), inflammatory bowel disease (n=2), heart disease (n=2), hypertension (n=1), and brain disease (n=1). As in those reported cases, our series did not indicate that PG was associated with any particular disease. Table 4 summarizes the tumor characteristics in the reported cases. The most common location was in the ileum [n=21 (60.0%)], followed by the jejunum [n=11 (31.4%)] and the duodenum [n=3 (8.6%)]. The median tumor size was 10.0 mm (3-60 mm), with no particular form predominating [sessile polyps, n=10 (34.5%), semi-pedunculated polyps, n=10 (37.9%), and pedunculated polyps, n=8 (27.6%)]. Surgery was performed in 23 cases (65.7%), while EMR was performed in 9 (25.7%). The endoscopic and morphologic characteristics of our case series were similar to those reported in the literature; however, we were able to remove the lesion endoscopically in the majority of our patients. Although there is no guideline on the endoscopic resection of small intestinal polyps, semi-pedunculated-or pedunculated-type PG without a non-lifting sing is considered to be an indication for endoscopic treatment, because the risk of perforation is relatively low. In symptomatic pa- (5) reported a PG that invaded the lower serosal layer via connective tissue in the muscle layers. Thus, preoperative EUS is also recommended so that incomplete endoscopic resection can be avoided. In addition, one of our cases experienced oozing bleeding, which was difficult to stop after a biopsy before endoscopic resection. Since PG is a polyp with abundant capillaries on its surface, in cases in which PG is suspected, EMR should be applied as a diagnostic therapy without biopsy. The Japan Gastroenterological Endoscopy Society guidelines for OGIB (38) recommend dynamic computed tomography (CT) as the initial approach. However, when the source of the hemorrhage is a small lesion such as a PG, it is often not detectable on CT. CT did not demonstrate PG in any of our cases, whereas CE did. Moreover, CE provides a good estimation of the location of the bleeding point in the small intestine, indicating where the treating enteroscope should be inserted. Although CT is effective for detecting small intestinal stenosis, which allows the avoidance of CE retention, small lesions like PG can be difficult to detect without direct visualization with a modality like CE. In our cases, there were more lesions of <10 mm in size in comparison to previous reports. Thus, we couldn't detect the bleeding sources with CT. Moreover, when CE was performed, half of the first CE examinations did not detect PGs. If the bleeding source cannot be identified by a single CE examination, repeated CE should be considered to obtain a definitive diagnosis. Several studies have reported that if overt bleeding, such as melena or hematochezia, is observed, then urgent CE within 24 hours increased the rate at which the bleeding source was detected from 44.2-56% to 87-92.3% (39) (40) (41) . Consequently, urgent CE is one option to identify OGIB sources.
In conclusion, PG is a possible, albeit rare, cause of OGIB. CE is the modality that is most likely to successfully detect PG. EMR should be the first-line approach in therapy; however, an EUS examination is recommended to minimize the chance of incomplete resection.
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